Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.77 |
| ▸ | KDM5A | P29375 | 3/20 | 0.47 |
| ▸ | PHF8 | Q9UPP1 | 3/20 | 0.47 |
| ▸ | KDM2A | Q9Y2K7 | 3/20 | 0.47 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.47 |
| ▸ | KDM4A | O75164 | 1/20 | 0.47 |
| ▸ | RAD52 | P43351 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | NMT2 | O60551 | 1/20 | 0.41 |
| ▸ | NMT1 | P30419 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL10697793 | 0.92 | SIGMAR1 (0.63) | SIGMAR1KDM5APHF8KDM2AKDM4C | |
| SCHEMBL13951245 | 0.88 | SIGMAR1 (1.00) | SIGMAR1RAD52CYP1A2 | |
| SCHEMBL20925672 | 0.88 | SIGMAR1 (1.00) | SIGMAR1RAD52CYP1A2 | |
| SCHEMBL4871113 | 0.88 | SIGMAR1 (1.00) | SIGMAR1RAD52CYP1A2 | |
| SCHEMBL9718061 | 0.88 | SIGMAR1 (1.00) | SIGMAR1RAD52CYP1A2 | |
| SCHEMBL24556958 | 0.88 | SIGMAR1 (1.00) | SIGMAR1RAD52CYP1A2 | |
| SCHEMBL5072429 | 0.88 | SIGMAR1 (1.00) | SIGMAR1RAD52CYP1A2 | |
| SCHEMBL18962201 | 0.88 | SIGMAR1 (1.00) | SIGMAR1RAD52CYP1A2 | |
| SCHEMBL9293966 | 0.88 | SIGMAR1 (1.00) | SIGMAR1RAD52CYP1A2 | |
| SCHEMBL10435740 | 0.88 | SIGMAR1 (1.00) | SIGMAR1RAD52CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6057371-A | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, GASTROINTESTINAL DISORDERS, DRUG ABUSE, ANGINA, MIGRAINE, HYPERTENSION AND DEPRESSION | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2000-05-02 | — | — | US | disclosed |
| EP-0591426-A1 | SIGMA RECEPTOR LIGANDS AND THE USE THEREOF | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1994-04-13 | — | — | EP | disclosed |
| WO-1993000313-A2 | SIGMA RECEPTOR LIGANDS AND THE USE THEREOF | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1993-01-07 | — | — | WO | disclosed |